Herein we report the development and application of a novel ER:PR-B interaction assay using PLA that can be used in FFPE breast cancer tissue sections and show that the frequency of these interactions is able to predict response to adjuvant AI therapy. The gene discussed is RB1; the disease is breast cancer.